Active Crohn disease and hypercalcemia treated with infliximab: Case report and literature review

Endocrine Practice

Volumn 14, Issue 1, 2008, Pages 87-92

  Ioachimescu, Adriana G ^a   Bauer, Thomas W ^a   Licata, Angelo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCORTISONE; INFLIXIMAB; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; VITAMIN D;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; ILEOSTOMY; MALE; MONOTHERAPY; RECURRENT DISEASE; BLOOD; MIDDLE AGED;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CALCITRIOL; CALCIUM; CROHN DISEASE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; PARATHYROID HORMONE; VITAMIN D;

EID: 40649123073     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.1.87     Document Type: Article

References (35)

1. Adams JS, Gacad MA. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med. 1985;161(4):755-765.
2. Lin JH, Chen W, Lee JY, Yan JJ, Huang JJ. Disseminated cutaneous Mycobacterium haemophilum infection with severe hypercalcaemia in a failed renal transplant recipient [erratum in Br J Dermatol. 2004;150:178]. Br J Dermatol. 2003;149:200-202.
3. Playford EG, Bansal AS, Looke DF, Whitby M, Hogan PG. Hypercalcaemia and elevated 1,25(OH)(2)D(3) levels associated with disseminated Mycobacterium avium infection in AIDS. J Infect. 2001;42:157-158.
4. Peces R, Pobes A, Díaz-Corte C, Gago E. Hypercalcemia, inappropriate calcitriol levels, and tuberculosis on hemodialysis. Scand J Urol Nephrol. 2000;34:287-288.
5. Hewison M, Kantorovich V, Liker HR, et al. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003;18:579-582.
6. Jurney TH. Hypercalcemia in a patient with eosinophilic granuloma. Am J Med. 1984;76:527-528.
7. Shaker JL, Redlin KC, Warren GV, Findling JW. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis. Am J Med Sci. 1994;308:115-118.
8. Caldwell JW, Arsura EL, Kilgore WB, Reddy CM, Johnson RH. Hypercalcemia in patients with disseminated coccidioidomycosis. Am J Med Sci. 2004;327:15-18.
9. Murray JJ, Heim CR. Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D. Am J Med. 1985;78:881-884.
10. Liang KV, Ryu JH, Matteson EL. Histoplasmosis with tenosynovitis of the hand and hypercalcemia mimicking sarcoidosis. J Clin Rheumatol. 2004;10:138-142.
11. Adams JS, Singer FR, Gacad MA, et al. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab. 1985;60:960-966.
12. Kantarjian HM, Saad MF, Estey EH, Sellin RV, Samaan NA. Hypercalcemia in disseminated candidiasis. Am J Med. 1983;74:721-724.
13. Sinnott BP, Licata AA. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract. 2006;12:622-629.
14. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192-199.
15. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut. 1985;26:1197-1203.
16. Harpavat M, Keljo DJ, Regueiro MD. Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol. 2004;38:218-224.
17. Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2006;23:1007-1016.
18. Bosch X. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease. Gastroenterology. 1998;114:1061-1065.
19. Tuohy KA, Steinman TI. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn's disease. Am J Kidney Dis. 2005;45:3-6.
20. Zehnder D, Bland R, Williams MC, et al. Extrarenal Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-894.
21. Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol. 2004;39:527-533.
22. Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxy-cholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr. 1991;54:548-552.
23. Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004;53:1129-1136.
24. Studdy P, Bird R, James DG. Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders. Lancet. 1978;2:1331-1334.
25. Lufkin EG, DeRemee RA, Rohrbach MS. The predictive value of serum angiotensin-converting enzyme activity in the differential diagnosis of hypercalcemia. Mayo Clin Proc. 1983;58:447-451.
26. D'Onofrio GM, Levitt S, Ilett KF. Serum angiotensin converting enzyme in Crohn's disease, ulcerative colitis and peptic ulceration. Aust N Z J Med. 1984;14:27-30.
27. Matsuda T, Suzuki J, Furuya K, Masutani M, Kawakami Y. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype. Am J Gastroenterol. 2001;96:2705-2710.
28. Nunez-Gornes JF, Tewksbury DA. Serum angiotensin-converting-enzyme in Crohn's disease. Am J Gastroenterol. 1981;75:384-385.
29. Sommer H, Schweisfurth H, Schulz M. Serum angiotensin-I-converting enzyme and carboxypeptidase N in Crohn's disease and ulcerative colitis. Enzyme. 1986;35:181-188.
30. Familiari G, Creperio G, Ranzini C, Ferrara A. Involvement of the polypeptide system and ACE in Crohn disease [article in Italian]. Minerva Med. 1987;78:841-845.
31. Rahimi R, Nikfar S, Abdollahi M. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials. Biomed Pharmacother. 2007;61:75-80.
32. Richter JA, Bickston SJ. Infliximab use in luminal Crohn's disease. Gastroenterol Clin North Am. 2006;35:775-793.
33. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med. 1989;111:437-438.
34. Barré PE, Gascon-Barré M, Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med. 1987;82:1259-1262.
35. Menon Y, Cucurull E, Reisin E, Espinoza LR. Interferonalpha- associated sarcoidosis responsive to infliximab therapy. Am J Med Sci. 2004;328:173-175.